Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients (2021) | Federal Compass

Free Market Report: Trends & Observations
Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients (2021)


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services » National Institutes of Health » National Cancer Institute
NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences
Competition Set-Aside Type
NONE

Award Type
IDC
Award Date
09/23/2021
Expiration Date
09/25/2028
No. of Awards
3
No. of Offers
4

Obligations by Fiscal Year

prime obligations by fiscal year

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Contracting Resources